Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Sell
38
ABTZY Quote, Financials, Valuation and Earnings
Last price:
$6.26
Seasonality move
:
3.65%
Day range:
$6.26 - $6.26
52-week range:
$5.92 - $9.34
Dividend yield:
4%
P/E ratio:
8.17x
P/S ratio:
0.66x
P/B ratio:
0.69x
Volume:
--
Avg. volume:
33
1-year change:
-32.83%
Market cap:
$3.5B
Revenue:
$5.6B
EPS (TTM):
$0.77
Analysts' Opinion
-
Consensus RatingAboitiz Equity Ventures has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Aboitiz Equity Ventures has an estimated downside of -- from its current price of $6.26.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $6.26.
Fair Value
-
According to the consensus of 0 analysts, Aboitiz Equity Ventures has -- downside to fair value with a price target of -- per share.
ABTZY vs. S&P 500
-
Over the past 5 trading days, Aboitiz Equity Ventures has underperformed the S&P 500 by -1.71% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Aboitiz Equity Ventures does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Aboitiz Equity Ventures revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Aboitiz Equity Ventures reported revenues of $1.2B.
Earnings Growth
-
Aboitiz Equity Ventures earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Aboitiz Equity Ventures reported earnings per share of $0.23.
Enterprise value:
10.6B
EV / Invested capital:
0.78x
Price / LTM sales:
0.66x
EV / EBIT:
7.86x
EV / Revenue:
2.01x
PEG ratio (5yr expected):
0.50x
EV / Free cash flow:
14.78x
Price / Operating cash flow:
4.89x
Enterprise value / EBITDA:
6.55x
Gross Profit (TTM):
$1.9B
Return On Assets:
2.88%
Net Income Margin (TTM):
8.12%
Return On Equity:
6.42%
Return On Invested Capital:
3.22%
Operating Margin:
20.98%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $5.3B | $5.8B | $5.3B | $1.3B | $1.2B | |
| Gross Profit | $1.2B | $1.6B | $1.9B | $185.1M | $262.1M | |
| Operating Income | $751M | $590.9M | $818.4M | $185.1M | $262.1M | |
| EBITDA | $1.4B | $1.5B | $1.6B | $412.6M | $441.1M | |
| Diluted EPS | $0.93 | $0.66 | $0.77 | $0.24 | $0.23 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3.1B | $3.1B | $4.1B | $4.2B | $3.8B | |
| Total Assets | $12.6B | $12.4B | $13B | $14.6B | $15B | |
| Current Liabilities | $2.3B | $2B | $2.1B | $2.2B | $2.1B | |
| Total Liabilities | $8.1B | $7.5B | $7B | $8.1B | $8.1B | |
| Total Equity | $4.4B | $4.9B | $6B | $6.5B | $7B | |
| Total Debt | $6B | $5.6B | $5.3B | $6.4B | $6.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $384M | $1.1B | $1.1B | $303.9M | $295.2M | |
| Cash From Investing | -$1.1B | -$470.6M | -$488.5M | -$244.5M | $78.2M | |
| Cash From Financing | $1.1B | $291.4M | -$1.1B | $224.2M | -$275.3M | |
| Free Cash Flow | $95.5M | $618.4M | $715.5M | $192.2M | $201.8M | |
ABTZY
Sector
Market Cap
$3.5B
--
Price % of 52-Week High
67.02%
--
Dividend Yield
4%
--
Shareholder Yield
--
--
1-Year Price Total Return
-32.83%
--
Beta (5-Year)
0.063
--
Dividend yield:
4%
Annualized payout:
$0.27
Payout ratio:
32.42%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$6.26
200-day SMA
Sell
Level
$7.14
Bollinger Bands (100)
Sell
Level
6.22 - 6.32
Chaikin Money Flow
Buy
Level
11.7K
20-day SMA
Sell
Level
$6.26
Relative Strength Index (RSI14)
Buy
Level
51.95
ADX Line
Neutral
Level
Williams %R
Buy
Level
0
50-day SMA
Sell
Level
$6.26
MACD (12, 26)
Sell
Level
0.00
25-day Aroon Oscillator
Sell
Level
0
On Balance Volume
Neutral
Level
15.5K
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Sell
CA Score
(Annual)
Level (-0.7439)
Buy
Beneish M-Score
(Annual)
Level (-2.6511)
Buy
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-0.6468)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Aboitiz Equity Ventures Inc is a Philippines holding company with reportable segments of power distribution and generation, financial services, food manufacturing, real estate, and infrastructure. The power segment is engaged in power generation and the sale of electricity. The food manufacturing segment is engaged in the production of flour and feeds and swine breeding. Aboitiz Equity Ventures generates maximum revenue from the power segment. Geographically, it operates solely in the Philippines.
Stock Forecast FAQ
In the current month, ABTZY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ABTZY average analyst price target in the past 3 months is --.
-
Where Will Aboitiz Equity Ventures Stock Be In 1 Year?
According to analysts, the consensus estimate is that Aboitiz Equity Ventures share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Aboitiz Equity Ventures?
Analysts are divided on their view about Aboitiz Equity Ventures share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Aboitiz Equity Ventures is a Sell and believe this share price will rise from its current level to --.
-
What Is Aboitiz Equity Ventures's Price Target?
The price target for Aboitiz Equity Ventures over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ABTZY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Aboitiz Equity Ventures is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ABTZY?
You can purchase shares of Aboitiz Equity Ventures via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Aboitiz Equity Ventures shares.
-
What Is The Aboitiz Equity Ventures Share Price Today?
Aboitiz Equity Ventures was last trading at $6.26 per share. This represents the most recent stock quote for Aboitiz Equity Ventures. Yesterday, Aboitiz Equity Ventures closed at $6.26 per share.
-
How To Buy Aboitiz Equity Ventures Stock Online?
In order to purchase Aboitiz Equity Ventures stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
73
PSIX alert for Dec 24
Power Solutions International [PSIX] is up 19.35% over the past day.
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is up 7.91% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is down 1.39% over the past day.
